Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion type Assertion NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_head.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion description "[Lipopolysaccharide (LPS)- or 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated Raw 264.7 cells and ICR mice were treated with PEP-1-FK506BP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_provenance.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion evidence source_evidence_literature NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_provenance.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion SIO_000772 21288594 NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_provenance.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion wasDerivedFrom befree-20140225 NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_provenance.
- NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_assertion wasGeneratedBy ECO_0000203 NP278041.RA5fLwgsjrqOFcwEDeM5V-NLixSITDJi2pBNqNhNN9Elo130_provenance.